Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin actionYan Shu, Kathleen M. Giacomini|Journal of Clinical Investigation|2007Cited by 951
The Pharmacogenetics Research Network: From SNP Discovery to Clinical Drug ResponseKathleen M. Giacomini, Issam Zineh, Dan M. Roden et al.|Clinical Pharmacology & Therapeutics|2007Cited by 243
OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metforminLigong Chen, Kathleen M. Giacomini, Yan Shu et al.|Proceedings of the National Academy of Sciences|2014Cited by 237
Targeted Disruption of Organic Cation Transporter 3 Attenuates the Pharmacologic Response to MetforminEugene C. Chen, Kathleen M. Giacomini|Molecular Pharmacology|2015Cited by 101
Genetic Polymorphisms in Organic Cation Transporter 1 (OCT1) in Chinese and Japanese Populations Exhibit Altered FunctionLigong Chen, Kathleen M. Giacomini|Journal of Pharmacology and Experimental Therapeutics|2010Cited by 95